Chemotherapy and Targeted Therapy

MeiraGTx Secures $400 Million Strategic Funding to Propel Late-Stage Gene Therapy Pipeline meiragtx-secures-400-million-strategic-funding-to-propel-late-stage-gene-therapy-pipeline

MeiraGTx Secures $400 Million Strategic Funding to Propel Late-Stage Gene Therapy Pipeline

Azzam Bilal Chamdy July 7, 2026

By Delilah Alvarado Published July 7, 2026 In a significant show of investor confidence within the volatile...

Innovation at the Intersection: PharmSci 360 2026 Set to Define the Future of Drug Development in New Orleans innovation-at-the-intersection-pharmsci-360-2026-set-to-define-the-future-of-drug-development-in-new-orleans

Innovation at the Intersection: PharmSci 360 2026 Set to Define the Future of Drug Development in New Orleans

Muslim July 7, 2026

As the pharmaceutical landscape undergoes a seismic shift driven by artificial intelligence, complex biologics, and a heightened...

The Biotech Heartland Shift: Why Innovation is Migrating Beyond the Boston-Cambridge Axis the-biotech-heartland-shift-why-innovation-is-migrating-beyond-the-boston-cambridge-axis

The Biotech Heartland Shift: Why Innovation is Migrating Beyond the Boston-Cambridge Axis

Nila Kartika Wati July 7, 2026

For decades, the mention of "biotech" in the United States evoked one immediate mental image: the gleaming...

Bridging the Gap: How Novel Immunotherapies Are Redefining the Treatment of TBI and Alzheimer’s Disease bridging-the-gap-how-novel-immunotherapies-are-redefining-the-treatment-of-tbi-and-alzheimers-disease

Bridging the Gap: How Novel Immunotherapies Are Redefining the Treatment of TBI and Alzheimer’s Disease

Azzam Bilal Chamdy July 7, 2026

Traumatic brain injury (TBI) is a silent global epidemic. Affecting an estimated 69 million people annually, TBI...

Novartis Enters the ADC Arena: A $1.5 Billion Strategic Pivot into Next-Generation Oncology novartis-enters-the-adc-arena-a-1-5-billion-strategic-pivot-into-next-generation-oncology

Novartis Enters the ADC Arena: A $1.5 Billion Strategic Pivot into Next-Generation Oncology

Iffa Jayyana July 6, 2026

In a decisive move to reshape its oncology pipeline, Swiss pharmaceutical titan Novartis has announced its intention...

The Science of Precision: Why Patient Matching is the Bedrock of Credible Real-World Evidence the-science-of-precision-why-patient-matching-is-the-bedrock-of-credible-real-world-evidence

The Science of Precision: Why Patient Matching is the Bedrock of Credible Real-World Evidence

Laily UPN July 6, 2026

In the modern clinical landscape, the distance between a "hunch" and a "scientific finding" is measured by...

The Double-Edged Sword: Eli Lilly’s Retatrutide and the New Frontier of Obesity Medicine the-double-edged-sword-eli-lillys-retatrutide-and-the-new-frontier-of-obesity-medicine

The Double-Edged Sword: Eli Lilly’s Retatrutide and the New Frontier of Obesity Medicine

Lina Irawan July 6, 2026

In the rapidly evolving landscape of metabolic health, Eli Lilly has reached a new milestone with its...

Global Race Against Time: CEPI Accelerates Development of Three Bundibugyo Ebola Vaccine Candidates global-race-against-time-cepi-accelerates-development-of-three-bundibugyo-ebola-vaccine-candidates

Global Race Against Time: CEPI Accelerates Development of Three Bundibugyo Ebola Vaccine Candidates

Layla Zulfa July 6, 2026

In a critical move to curb the escalating threat of the Bundibugyo ebolavirus (BDBV) in the Democratic...

Beyond Weight Loss: How Retatrutide is Reshaping the Metabolic Landscape beyond-weight-loss-how-retatrutide-is-reshaping-the-metabolic-landscape

Beyond Weight Loss: How Retatrutide is Reshaping the Metabolic Landscape

Muslim July 5, 2026

The pharmaceutical industry is witnessing a seismic shift in the treatment of metabolic diseases. At the American...

Shifting the Paradigm: How ADME-One is Moving Human PK Projection to the Front Lines of Drug Discovery shifting-the-paradigm-how-adme-one-is-moving-human-pk-projection-to-the-front-lines-of-drug-discovery

Shifting the Paradigm: How ADME-One is Moving Human PK Projection to the Front Lines of Drug Discovery

Asep Darmawan July 5, 2026

For decades, the pharmaceutical industry has operated under a rigid, linear philosophy: discover a potent molecule first,...

Chemotherapy and Targeted Therapy

MeiraGTx Secures $400 Million Strategic Funding to Propel Late-Stage Gene Therapy Pipeline

Innovation at the Intersection: PharmSci 360 2026 Set to Define the Future of Drug Development in New Orleans

The Biotech Heartland Shift: Why Innovation is Migrating Beyond the Boston-Cambridge Axis

Bridging the Gap: How Novel Immunotherapies Are Redefining the Treatment of TBI and Alzheimer’s Disease

Novartis Enters the ADC Arena: A $1.5 Billion Strategic Pivot into Next-Generation Oncology

The Science of Precision: Why Patient Matching is the Bedrock of Credible Real-World Evidence

The Double-Edged Sword: Eli Lilly’s Retatrutide and the New Frontier of Obesity Medicine

Global Race Against Time: CEPI Accelerates Development of Three Bundibugyo Ebola Vaccine Candidates

Beyond Weight Loss: How Retatrutide is Reshaping the Metabolic Landscape

Shifting the Paradigm: How ADME-One is Moving Human PK Projection to the Front Lines of Drug Discovery

You may have missed

Ibuprofen: Beyond Pain Relief – Unveiling its Unexpected Anti-Cancer Potential

A Paradigm Shift in HIV Care: Gilead and Merck’s Once-Weekly Regimen Passes Phase 3 Milestone

Beyond Wrinkles: The Emerging Role of Botox in Revolutionizing Scar Management

The Radiology Crisis: Escalating Costs and Workforce Shortages Threaten Patient Care